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ABSTRACT
Aims: To explore: (1) whether during exercise
metabolic equivalents (METs) appropriately indicate the
intensity and/or metabolic cost for post-myocardial
infarction (MI) males and (2) whether post-exercise
VO2 parameters provide insight into the intensity and/
or metabolic cost of the prior exercise.
Methods: 15 male phase-IV post-MIs (64.46.5
years) and 16 apparently healthy males (63.06.4
years) participated. Participants performed a graded
cycle ergometer test (CET) of 50, 75 and 100 W,
followed by 10 min active recovery (at 50 W) and 22
min seated recovery. Participants’ heart rate (HR,
bpm), expired air parameters and ratings of perceived
exertion (exercise only) were measured.
Results: General linear model analysis showed
throughout significantly lower HR values in post-MI
participants that were related to b-blocker medication
(F(2,5)=18.47, p<0.01), with significantly higher VCO2/
VO2 (F(2,5)=11.25, p<0.001) and gross kcals/LO2/min
(F(2,5)=11.25, p<0.001). Analysis comparing lines of
regression showed, during the CET: post-MI
participants worked at higher percentage of their
anaerobic threshold (%AT)/MET than controls
(F(2,90)=18.98, p<0.001), as well as during active
recovery (100–50 W) (F(2,56)=20.81, p<0.001); during
seated recovery: GLM analysis showed significantly
higher values of VCO2/VO2 for post-MI participants
compared with controls (F(2,3)=21.48, p=0.001) as well
as gross kcals/LO2/min (F(2,3)=21.48, p=0.001).
Conclusion: Since METs take no consideration of any
anaerobic component, they failed to reflect the
significantly greater anaerobic contribution during
exercise per MET for phase-IV post-MI patients. Given
the anaerobic component will be greater for those with
more severe forms of cardiac disease, current METs
should be used with caution when determining
exercise intensity in any patient with cardiac disease.
INTRODUCTION
Post-myocardial infarction (MI) patients
make up the largest proportion of cardiac
rehabilitation participants in England,1 and
while considerable research has been
conducted into the differences in physiolog-
ical responses to exercise in those with
more severe forms of heart disease, such as
heart failure,2–5 there are still relatively few
studies performed on those who have
suffered MIs.6 In particular, among those
who have completed cardiac rehabilitation
and exercise regularly within the commu-
nity (phase IV). Increasingly, researchers
have questioned the use of equations and
indices based on healthy individuals to esti-
mate exercise intensity and assist in physical
activity prescription in settings like cardiac
rehabilitation.7 –10
The primary aim of this study was to
explore whether current metabolic equiva-
lents (METs, 1 MET ~ VO2 of 3.5 mL/kg/
min) appropriately indicate exercise inten-
sity and/or metabolic cost of exercise in
phase-IV post-MI males. Additionally,
research has shown postexercise measures
of oxygen uptake parameters to provide
insight into the intensity of the prior exer-
cise in patients with cardiac disease.11
Therefore, a secondary aim was to observe
whether postexercise measures provided
further understanding into the intensity
What are the new findings?
" The percentage anaerobic component per
metabolic equivalent (%AT/MET) is significantly
higher for those with cardiac disease compared
with healthy individuals.
" Current METs underestimate the exercise inten-
sity and anaerobic demand of exercise for
patients with cardiac disease.
" Reducing METs to account for body composi-
tion does not reliably address the issue of
increased %AT/MET for those with cardiac
disease.
" Any value, indices or equation used in deter-
mining exercise intensity or in prescription of
exercise for patients with cardiac disease,
which does not consider the anaerobic compo-
nent, should be used with caution.
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and/or metabolic cost of a bout of cycle ergometry
when comparing phase-IV cardiac rehabilitation post-
MI patients with male controls.
METHODS
Ethical approval was provided by the local NHS
Research Ethics Committee and the University Faculty
of Social and Applied Science Research Ethics
Committee, ref: 09/H1101/34.
Power and sample size calculations
Based on a previously observed statistically significant
difference in VO2 of 2.31.8 mL/kg/min between
people with cardiac disease and those with normal heart
function during cycle ergometry,5 using Minitab statis-
tical package (version 17), 15 participants were required
in each group to achieve 90% power at an a of 0.05.
Participant recruitment
Fifteen men classified with an uncomplicated MI
(4.73.2 years since MI) were recruited through
community phase-IV cardiac rehabilitation exercise
classes. Sixteen apparently healthy volunteers were
recruited from the same area through word of mouth
and posters. All volunteers were given a Participant
Information Sheet and interested individuals
were asked to complete a Health and Physical Activity
Screening Questionnaire. The post-MI volunteers were
required to be ‘uncomplicated’, stable, at phase-IV
cardiac rehabilitation level, taking standard medica-
tions, such as, statin, b-blocker, aspirin and
ACE inhibitor. Potential controls were to be free of
cardiac disease and/or event and/or chronic medical
condition and/or taking long-term medications. All
participants were required to be non-smoking, under-
stand the nature of the study, aged between 50 and 75
years, perform similar levels of regular physical activity
and free of any orthopaedic limitations during exer-
cise. Participants that cleared screening were required
to provide written informed consent and written
acknowledgement of their participation from their
general practitioner. Participants were free to withdraw
from the study at any time without providing a reason.
Procedures
All data were collected in the same Exercise Labora-
tory. On arrival, each participant was measured for
height (Stadiometer Seca 220, Seca, Hamburg,
Germany) and body mass (Seca 710, Seca), thus body
mass index was derived. Each participant then sat
quietly for 10 min while measures of resting blood
pressure (mm Hg) (Yamasu Mercurial Spygmomanom-
eter 605P; Kenzmedico, Japan) and heart rate
(HR, bpm) (Polar Model S810, Kempele, Finland,
worn on strap around chest) were recorded in accor-
dance with Association Chartered Physiotherapists in
Cardiac Rehabilitation (ACPICR)12 guidelines for pre-
exercise checks. Following these measures, respiratory
function forced vital capacity and forced expiratory
volume in 1 s was recorded by forced exhalation into a
portable Spirometer. A total of three spirometry tests
were performed with short recovery, and the best was
recorded.
Prior to each participant’s assessments, equipment
was calibrated. To provide an indication of pre-exer-
cise resting VO2, expired air was collected via a Hans
Rudolph breathing valve (2700; Hans Rudolph, Kansas
City, MO, USA) and plastic tubing into a Douglas bag
(Model 6170, 170 L capacity non-diffusing gas collec-
tion bag, Hans Rudolph). A nose clip was worn and
each participant sat quietly for 5 min. The final minute
of collection was used in analysis. The expired gas was
analysed using a gas analyser (Servomex, West Sussex,
UK). The expired volume of air was measured using a
dry gas meter (Harvard Apparatus, Kent, UK) by evac-
uating each Douglas bag using a vacuum pump.
Upright cycle ergometer test
During cycle ergometer test (CET), active recovery and
seated recovery, VO2 and CO2 production were measured
using the Douglas bag method, the ‘gold standard’ for
measuring efficiency,13 coefficient of variation was <0.5%
for both O2 and CO2,
14 methods previously described.
Expired gases were collected over the final minute of each
6 min wattage stage and during active and seated
recovery, along with ratings of perceived exertion (RPE)
Borg 6–20 scale15 (exercise only). The gross energetic
equivalent/metabolic cost of VCO2/VO2 was calculated




This study adopted a methodology in accordance
with recommendations for exercise testing cardiac
populations,12 including an extended postexercise
period, as patients with cardiac disease require more
time to return to pre-exercise levels.17 18 The protocol
was designed to address criticisms of previous
studies19–21; therefore, measures were taken comparing
gross efficiency in patients and controls at the same
‘absolute’ workloads to gain a ‘truer’ indication of exer-
cise cost.22 Following pre-exercise resting measures,
each participant undertook the CET. This was
performed on a SRM cycle erogmeter (Schoberer Rad
Messtechnik, Julich, Germany) with seat height
adjusted to ensure that participants’ knees were slightly
bent when the pedal was at the bottom of the crank
stroke. Exercise started at a low intensity acting as a
warm-up.12 Exercise intensity was increased every 6
min until three incremental levels were completed (50,
75 and 100 W, respectively). Cadence was set at 60
revolutions per minute (rpm), shown to be most
economical across a range of power outputs.22–24
Therefore, in line with recommendations, termination
point should have been just below maximum
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intensity.12 This was immediately followed by 10 min
active recovery at 50 W with 60 rpm.
Postexercise VO2 parameters
After active recovery, participants were seated, expired
air continued to be collected and measured during
10th to 11th and 21st to 22nd min.
Data analysis
Statistical analysis was performed using Minitab statis-
tical package (version 17), with a 5% level of
significance. Bonferroni correction factor was applied
where appropriate, which shifted the point of statistical
significance. Variability of data within a distribution
was given as 1 SD (meanSD). Baseline differences
between groups were determined using an indepen-
dent t-test. General linear model was used to compare
differences in the measured variables between the
groups during and post-CET. One-way analysis of vari-
ance was used post hoc to determine differences
between groups at individual data collection points.
VCO2/VO2=1.0 was used to describe point of anaerobic
threshold (AT) as this has been shown to correlate
highly with blood lactate values and deemed appro-
priate when testing patients with cardiac disease,
where HR values are unreliable.25 Regression analysis
comparing lines of trajectory determine the difference
between percentages of AT (%AT) versus METs rela-
tionship (%AT/MET) between groups. All data were
double checked for transcript errors.
RESULTS
Participants
Table 1 shows participant characteristics at baseline.
Medications
Since all post-MI participants were taking both b-
blockers and a statin (all but one participant, table 2),
the statistical effect of both were similar to the group
effect. It is likely that the reduced HR values for the
post-MI participants throughout were due to their b-
blocker medication. There were few participants taking
other medications (table 2) to determine any
Table 1 Participant characteristics at baseline, meanSD (range)
Post-MIs (n=15, mean±SD (range)) Controls (n=16, mean±SD (range))
Age (years) 64.46.5 (53–73) 63.06.4 (51–73)
Height (m) 1.780.06 (1.64–1.91) 1.760.07 (1.63–1.85)
Body mass (kg) 88.413.5 (64.5–113.0) 83.110.5 (65.5–98.0)
BMI (kg/m2) 27.73.7 (20.6–36.5) 26.63.2 (18.9–32.0)
Pre-exercise resting
SBP (mm Hg) 131.814.0 (112–159) 139.314.1 (121–161)
DBP (mm Hg) 78.97.0 (69–94) 82.77.6 (69–96)
HR (bpm) 58.77.4 (48–73)* 70.310.9 (55–89)
VO2 (mL/kg/min) 3.470.57 (2.31–4.31) 3.610.56 (2.24–4.38)
VO2 (L/min) 0.310.05 (0.28–0.37) 0.300.02 (0.18–0.37)
VCO2 (L/min) 0.320.09 (0.15–0.44) 0.300.12 (0.14–0.64)
VE (L/min) 11.94.4 (6.3–19.7) 9.863.4 (5.1–18.9)
kcal/LO2/min 5.250.13 (5.01–5.36) 5.250.08 (5.12–5.36)
RPP (HRxSBP (mm Hg)) 7692990 (6426–10176)† 97491504 (7112–11932)
VCO2/ VO2 (L/min) 1.020.18 (0.74–1.37) 0.960.24 (0.77–1.75)
FVC 4.40.9 (3.5–6.8) 4.50.7 (3.3–5.7)
FEV1 3.20.5 (2.4–4.2) 3.40.6 (2.5–4.5)
Weekly physical activity (self-reported)
30 min sessions at moderate intensity 4.62.0 (1–7)† 2.81.8 (0–7)
20 min sessions at vigorous intensity 1.61.2 (0–5) 1.41.5 (0–4)
*Statistically significantly different from controls at p 0.05.
†Statistically significantly different from controls at p 0.01.
BMI, body mass index; DBP, diastolic blood pressure; FEV1, air volume exhaled at the end of the first second of forced expiration/forced
expiratory volume in 1 s; FVC, forced vital capacity; HR, heart rate; kcal/LO2/min, kilocalories per litre of oxygen uptake per minute; RPP,
rate pressure product; SBP, systolic blood pressure; VCO2, carbon dioxide expired; VO2, oxygen uptake; VE, minute ventilation.
Table 2 Number of post-MIs taking various
cardiovascular medications









Angiotensin receptor antagonist 2
a-blocker 1
Potassium channel activator 1
MIs, myocardial infarctions.
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meaningful statistical effect on any of the measured
variables.
Cycle ergometer test
Bonferroni shifted significance to p <0.017, analysis
revealed HR (F(2,3)=17.64, p<0.001) to be significantly
lower in post-MI participants with no significant differ-
ence in any of the other measured variables between
groups (table 3). Post-MIs participants reached AT25 at
VO2 18.7 mL/kg/min (AT=68.60x1.0–49.95,
R2=0.998) compared with 22.8 mL/kg/min for controls
(AT=87.91x1.0–65.10, R2=0.996), which were signifi-
cantly different after Bonferroni shifted significance to
p<0.001 (F(2,90)=43.99, p<0.001); %AT/MET relation-
ship showed a significantly greater anaerobic
component per MET for the post-MI participants
compared with controls (F(2,90)=18.98, p<0.001).
Active recovery (100–50 W)
Bonferroni shifted significance to p<0.025, HR
(F(2,2)=17.59, p<0.001) was significantly lower for
post-MI participants, with no significant differences in
any other measured variables. Analysis comparing %
AT/METs relationship, where Bonferroni shifted signif-
icance to p<0.00, showed that %AT/MET was again
significantly greater for post-MIs (F(2,56)=20.81,
p<0.001).
Seated recovery
Bonferroni shifted significance to p<0.017, HR was
significantly lower (F(2,3)=17.59, p<0.001) for post-MI
participants, with greater VCO2/VO2 (F(2,3)=21.48,
p=0.001) and gross kcal/LO2/min values (F(2,3)=21.48,
p=0.001). Analysis comparing %AT/METs relationship
showed no significant difference between groups.
However, post-MI participants showed higher VCO2/
VO2 and subsequent gross kcal/LO2/min compared
with controls during the 11th (F(2,10)=11.14, p=0.002)
and 22nd min (F(2,10)=11.21, p=0.002) (table 3).
CET, active and seated recovery
Bonferroni shifted significance to p<0.001, %AT/
METs was significantly greater throughout for post-
MI participants compared with controls
(F(2,90)=9048.0, p<0.000) (figure 1), with significantly
greater gross kcal/LO2/min (F(2,179)=16.22, p<0.001).
DISCUSSION
Throughout the CET and active recovery there were
no significant differences between groups in RPE, VO2
parameters or derived METs. Therefore on first
inspection, current METs would appear to appropri-
ately estimate exercise intensity for the phase-IV post-
MIs. However, METs are based on multiples of relative
measures of resting VO2, which of course takes no
account of any anaerobic component. On this basis, the
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would be similar across populations. Yet, our findings
show this not to be so, as post-MI participants clearly
worked at a significantly higher percentage of their
AT25 per MET when compared with the controls across
the exercise intensity range (figure 1).
Increased anaerobic metabolism
Using the same statistical methods, reanalysis was
conducted on data taken from two published
studies10 26 and from another paper27 that compared
phase-IV post-MI males with non-cardiac controls
during graded exercise. The findings revealed that
irrespective of different physiological and RPE
responses, for all studies, post-MIs worked more anaer-
obically per MET (%AT/MET), with varying degrees of
heteroscedasticity between studies as exercise intensity
increased. For example, Meadows and Woolf-May10
found that during a treadmill walking protocol of
speeds 2.0–4.4 miles/hour (figure 2), 17 post-MI partic-
ipants (aged 63.08.5 years) produced significantly
higher VO2 mL/kg/min values than 17 non-cardiac
males (aged 51.97.7 years) (F(2,8)=5.25, p<0.05) with
no significant differences in VCO2/VO2 or HR.
However, the study employing the Modified Bruce
treadmill walking test,27 involving 20 post-MI partici-
pants (aged 64.45.8 years) and 20 male controls
(aged 59.87.6 years), showed no significant differ-
ences between groups in VO2 mL/kg/min, again with
no differences in VCO2/VO2 or HR but the %AT/MET
was significantly greater for the post-MI participants.28
Reanalysis of the findings from the study comparing
two different 10-m shuttle walking test (SWT) protocols
(one using cones around which to turn, figure 3, and
the other without, figure 4),26 also using 20 post-MI
participants (aged 64.86.6 years) and 20 male
controls (aged 64.15.7 years), showed that during the
10-m SWT with cones, no significant differences in
VO2 parameters were observed, but RPE was higher
for post-MI participants (F(2,10)=4.78, p<0.05). During
the 10-m SWT with no cones however, post-MI partici-
pants displayed significantly greater VCO2/VO2
(F=23.51,p<0.01) and RPE (F=4.78, p<0.05) values
than the controls. For both 10-m SWT protocols, HR
values in post-MI participants were significantly lower
(F(2,10)=72.2, p<0.05), likely due to b-blocker
medication.26
Figure 1 Percentage of anaerobic threshold–metabolic
equivalent (MET) relationship throughout cycle ergometry,
active and seated recovery, for post-myocardial infarction
(MI) patients versus non-cardiac controls.
Figure 2 Percentage of anaerobic threshold–metabolic
equivalent (MET) relationship during graded treadmill walking
for post-myocardial infarction (MI) patients versus non-
cardiac controls.10
Figure 3 Percentage of anaerobic threshold–metabolic
equivalent (MET) relationship during the 10 m shuttle walking
test with cones for post-myocardial infarction (MI) patients
versus non-cardiac controls.26
Figure 4 Percentage of anaerobic threshold–metabolic
equivalent (MET) relationship during the 10 m shuttle walking
test without cones for post-myocardial infarction
(MI) patients versus non-cardiac controls.26
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Although it is clear that the single marker of VCO2/
VO2 equal to 1.0 may not be considered a ’true’ indi-
cator of AT, as shown by the high y axis figures seen in
figures 1-4, it does however represent an important
shift in metabolism. The fact that all post-MI partici-
pants of these studies work at a higher %AT/MET is
not to be unexpected, as it has been known since the
1960s that patients with cardiac disease reach the point
where VCO2/VO2 equals 1.0 at a lower VO2 (mL/kg/
min) than their non-cardiac counterparts,29 and the
more severe the heart disease, the sooner this point is
reached.2 However, METs, which take no account of
any anaerobic component are currently advocated by
the British Association of Cardiac Prevention and
Rehabilitation30 and the American Association of
Cardiovascular and Pulmonary Rehabilitation31 for use
in the prescription of exercise and determination of
exercise intensity to cardiac populations.
METs are often used synonymously to describe the
exercise intensity and energy expenditure/metabolic
cost of physical activity. While overall energy expendi-
ture was statistically significantly higher for the post-MI
participants in this study, pragmatically, this only
equated to a mean of 0.06 kcal/min. Yet, the anaerobic
component per MET was undoubtedly greater for the
post-MIs. For example, 5 METs, considered to be of
moderate intensity, for this study equated to 76.8%AT
for controls but 93.6%AT for the post-MI participants.
The difference of which increased with exercise inten-
sity, as 7 METs, considered to be of vigorous intensity,
equated to 101.5%AT for controls, but was 30% higher
for post-MI participants at 131%AT, an intensity
considered potentially hazardous for most of these
patients.
During exercise, at and beyond the point where
VCO2/VO2 equals 1.0, metabolic acidosis increases
exponentially. Therefore, for most patients with
cardiac disease, who reach this point sooner, similar
amounts of physical work would be more physically
demanding in comparison to non-cardiac individuals.
A study performed by Takagi et al6 observed that for
post-MI patients, even as soon as 218 days post-
event, the main factor limiting their exercise capacity
was related to their inability to use oxygen rather than
oxygen delivery per se, which was found due to skeletal
muscle deoxygenation abnormalities. The outcome
resulting in a slowing in oxygen kinetics,32 causing
greater reliance on anaerobic metabolism to meet the
demands of the physical work.33 Although similar find-
ings are well reported in those classified with heart
failure,29 32 34 there are relatively few reported studies
showing this in more physically able patients with
cardiac disease, such as phase-IV cardiac patients.
The increased reliance on anaerobic processes in
patients with cardiac disease is well reported and
largely multifactorial, potentially involving reductions
in cardiac output, neurohormonal/cytokine activation
and/or changes in skeletal muscle blood flow.6 35 36
Decreases in ‘efficient’ oxidative (type 1) skeletal
muscle fibres, oxidative enzymes, mitochondrial
density and muscle atrophy are mostly reported in
those with chronic heart failure,35–38 along with
reduced phosphocreatine stores and 50% higher ATP
consumption,3 all contributing to metabolic skeletal
muscle inefficiency.39 However, skeletal muscle
morphology can also occur in those with mild heart
failure,37 causing a higher reliance on anaerobic
processes11 20 and greater energy expenditure.3
Animal studies indicate the extent of these changes are
likely dependent on the size of MI and amount of left
ventricular dysfunction.36
Whether the medications taken by the post-MIs were
influential on our findings is difficult to determine. As
discussed in previous publications,8 10 both statins and
certain b-blocker medications can result in increased
reliance on anaerobic metabolism. b-blockers are
known to alter cardiorespiratory response by slowing
HR, thus affecting oxygen kinetics40 41 and reduce
skeletal muscle blood flow, consequently increasing
general fatigue.42 b-blockers have also been found
to have similar depressive effects on lipolysis as
statins43 44 and therefore potentially contributed
towards any shift towards anaerobic metabolism. The
very same participants taking b-blockers in this study
were also taking statins, thus producing statistically
similar results. High-dose statins may also lead to
muscle myopathy and interfere with fatty acid oxida-
tion, producing greater oxidation of carbohydrates,43
all potentially contributing to a shift towards anaerobic
processes as observed in the post-MI participants.
Body composition
Some researchers have suggested that for specific
populations the 1 MET value should be adjusted, espe-
cially for overweight45 46 and cardiac populations.7
Savage et al7 suggested that for normal and overweight
cardiac patients, the resting 1 MET should be reduced
to a VO2 of 2.84 mL/kg/min. To determine whether
this would apply, secondary analysis of this and the
other studies was performed.10 26 28 Analysis showed a
perfect correction in %AT/MET between post-MIs and
controls for this study, as for the Modified Bruce
protocol,28 and the 10-m SWT without the cones26
(p>0.05). However, for the 10-m SWT with the cones26
and treadmill walking study,10 the correction of 1 MET
of 2.8 4 mL/kg/min reversed the significant difference,
as controls now showed a greater %AT/ MET
(p <0.05). Thus indicating the adjustment to overcom-
pensate for certain protocols, suggesting body
composition not to be the only influential factor in
MET differences between cardiac and non-cardiac
populations.
During the Modified Bruce study, body composition
of the participants was measured.28 Analysis showed
only lean body mass to be influential, having a signifi-
cant effect on breathing frequency (F(2,5)=6.71,
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p<0.01). However, this was not sufficient to influence
the significantly higher breathing frequency observed
in the post-MI participants (F(2,5)=19.74, p<0.01),
which was not accompanied with significant differences
in minute ventilation (L/min) between groups. The
major factor to influence breathing frequency is usually
blood CO2 levels, leading to lowering in pH as CO2
increases.37 Therefore, the increased breathing
frequency of the post-MI would indicate the use of
enhanced anaerobic metabolism.28
Postexercise
Despite there being no observed differences in param-
eters of VO2 during the CET or active recovery, during
seated recovery, compared with controls, the post-MI
participants produced significantly elevated VCO2/VO2
values, taken during the 11th and 22nd min of expired
gas collection (table 3). This would indicate a slowing
in their O2 kinetics, producing higher proportions of
CO2, which continued for some time after exercise had
ceased.
In summary, it is clear that during exercise, current
METs, or METs adjusted for body weight, do not
consistently reflect the significantly higher anaerobic
component per MET observed in phase-IV post-MIs
when compared with the controls. Since the anaerobic
component is likely greater for patients with more
severe heart disease, any value, indices or equation
used in determining exercise intensity or in prescrip-
tion of exercise to cardiac patients, which does not
consider the anaerobic component, should be used
with caution.
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